|
May 30
|
Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
|
|
May 27
|
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
|
|
May 13
|
Q1 2025 Coherus BioSciences Inc Earnings Call
|
|
May 13
|
Coherus BioSciences Inc (CHRS) Q1 2025 Earnings Call Highlights: Strategic Growth and ...
|
|
May 12
|
Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 12
|
Coherus BioSciences: Q1 Earnings Snapshot
|
|
May 12
|
Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
|
|
Feb 12
|
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
|